REGISTERED
on 11 Apr 2023
Last Applicant/ Owned by
88 Sidney Street
Cambridge
MA
021394169
Serial Number
97104771 filed on 02th Nov 2021
Registration Number
7027627 registered on 11th Apr 2023
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
AGIOS
Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
First Use Date in General
25th Feb 2022
First Use Date in Commerce
25th Feb 2022
Class [042]
Computer & Software Services & Scientific Services
Providing pre-clinical, clinical and scientific research information in the field of pharmaceuticals including genetically defined diseases, hematologic disorders and diseases related to aberrant cellular metabolism
First Use Date in General
07th Jan 2022
First Use Date in Commerce
07th Jan 2022
Specimens
Mark Details
Serial Number
No 97104771
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.17.09 -
Curved line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Apr 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 11th Apr 2023 | REGISTERED-PRINCIPAL REGISTER |
| 10th Mar 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th Mar 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 07th Mar 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 07th Mar 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 19th Feb 2023 | TEAS STATEMENT OF USE RECEIVED |
| 19th Feb 2023 | USE AMENDMENT FILED |
| 23rd Aug 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 28th Jun 2022 | PUBLISHED FOR OPPOSITION |